Otospondylomegaepiphyseal dysplasia

From WikiMD's Medical Encyclopedia

(Redirected from Nance-Insley syndrome)

Otospondylomegaepiphyseal dysplasia (OSMED) is a rare genetic disorder that affects the development of the skeleton, hearing, and vision. It is characterized by short stature, severe hearing loss, and problems with vision. The condition is caused by mutations in the COL11A2 gene.

Symptoms and Signs[edit]

The most common symptoms of OSMED include short stature, severe hearing loss, and problems with vision. Other symptoms may include joint pain, skeletal abnormalities, and facial deformities. The severity of symptoms can vary greatly among individuals with the condition.

Causes[edit]

OSMED is caused by mutations in the COL11A2 gene. This gene provides instructions for making a protein that is essential for the normal development of cartilage and the formation of collagen, a protein that provides structure and strength to tissues and organs throughout the body. Mutations in the COL11A2 gene disrupt the normal development of cartilage and collagen, leading to the symptoms of OSMED.

Diagnosis[edit]

Diagnosis of OSMED is based on the presence of characteristic symptoms and signs. Genetic testing can confirm the diagnosis by identifying a mutation in the COL11A2 gene.

Treatment[edit]

There is currently no cure for OSMED. Treatment is focused on managing symptoms and improving quality of life. This may include hearing aids for hearing loss, physical therapy for joint pain and mobility issues, and surgery to correct skeletal abnormalities.

Prognosis[edit]

The prognosis for individuals with OSMED varies depending on the severity of symptoms. With appropriate management and treatment, many individuals with the condition can lead productive lives.

See Also[edit]

This article is a stub related to genetics. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.